New Report Shows Promising Coronavirus Vaccine Data
As vaccines are rolled out across the U.S., the light at the end of the tunnel of the coronavirus pandemic is getting brighter. Almost 30% of Americans have received at least one dose of a COVID-19 vaccine, but questions about their efficacy in preventing disease and viral transmission remain. Luckily, one recent study from across the world is reporting positive news about Pfizer (NYSE: PFE) and Moderna's (NASDAQ: MRNA) vaccines' capabilities.
Here's what new real-world data from Israel tells us about vaccines and transmissibility.
Source Fool.com
